向榮
向榮生技 Stock: price and insider trades · Taiwan
TW·Mcap NT$4.4B
向榮生技: what insiders have been doing
Only a handful of insider records exist for 向榮生技, the last one from 28 November 2025, too few to describe a trend. This summary is built from TWSE / TPEx (MOPS) disclosures alone and does not predict where the share price will go.
Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 18,797 of 26,912 companies
38.2
score / 100
Value27
Quality49
FCF yld-2.2%
Earn yld-2.6%
EV/EBITDA·
ROE-13%
Gross mgn63%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
NT$69
Analyst consensus
Income statement
RevenueNT$30.1M
Gross profitNT$19M63% margin
EBITDA-NT$92.9M-309% margin
Net income-NT$114.8M-381.5% margin
Valuation
P/Book5.3x
Beta-0.24
Balance sheet & cash
Market capNT$4.4B
Total debtNT$62M
Free Cash Flow-NT$97M
Debt / Equity7%
Profitability & ownership
ROE-13.1%
ROA-8.9%
% insiders56.8%
% institutions0.0%
Last declaration on 28 November 2025
Declarations5 total
- 9,899,000 sharesShareTWSETWMOPS:6794:114/11/28:君綺生醫股份有限公司:18spuxb
- 340,000 sharesShareTWSETWMOPS:6794:113/05/14:騰飛生技股份有限公司:0sfnzff
- 10,239,000 sharesShareTWSETWMOPS:6794:113/04/01:麗彤生醫科技股份有限公司:0q6z71y
- 800,000 sharesShareTWSETWMOPS:6794:111/01/07:麗彤生醫科技股份有限公司:0tgbaaf
- 2,200,000 sharesShareTWSETWMOPS:6794:110/03/26:蔡嘉櫸:1wjfpla
5 of 5 declarations
About 向榮生技
向榮生技 is a company listed on the XTAI market, specializing in the biotechnology sector. It focuses on developing innovative health solutions.